PJMHS 2022
DOI: 10.53350/pjmhs22169655
|View full text |Cite
|
Sign up to set email alerts
|

Frequency of in Stent Restenosis in Diabetic and Patients Undergoing PCI at Tertiary Care Cardiac Center

Abstract: Objective: To determine the frequency of in-stent restenosis in diabetic patients undergoing primary percutaneous coronary intervention (PCI). Study Design: Retrospective/Observational study Place and Duration: Department of Adult Cardiology, Peshawar Institute of Cardiology, Peshawar KPK During the Period from January, 2022 to June, 2022. Methodology: Total 380 patients of either gender with ages 25-70 years underwent primary percutaneous coronary intervention were enrolled. Patients were divided into two gro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Coronary intervention with stenting is recognized as the most effective treatment for both stable ischemic heart disease and acute coronary syndrome. However, stent thrombosis and in-stent restenosis (ISR) represent the most common complications following this procedure (1)(2)(3)(4). Previous studies have identified several risk factors associated with ISR post-percutaneous coronary intervention (PCI), including smoking (37.6%), hypertension (65.5%), diabetes mellitus (45.1%), hyperlipidemia (41.9%), and a familial history of coronary heart disease (16.7%).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Coronary intervention with stenting is recognized as the most effective treatment for both stable ischemic heart disease and acute coronary syndrome. However, stent thrombosis and in-stent restenosis (ISR) represent the most common complications following this procedure (1)(2)(3)(4). Previous studies have identified several risk factors associated with ISR post-percutaneous coronary intervention (PCI), including smoking (37.6%), hypertension (65.5%), diabetes mellitus (45.1%), hyperlipidemia (41.9%), and a familial history of coronary heart disease (16.7%).…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies have identified several risk factors associated with ISR post-percutaneous coronary intervention (PCI), including smoking (37.6%), hypertension (65.5%), diabetes mellitus (45.1%), hyperlipidemia (41.9%), and a familial history of coronary heart disease (16.7%). Another research focusing on patients who developed ISR after angioplasty found a high prevalence of hyperlipidemia (43.3%), hypertension (66.7%), smoking (46.7%), and a history of high blood pressure (66.7%) (1,(5)(6)(7)(8)(9)(10). Diabetes mellitus (DM) significantly contributes to the global burden of cardiovascular disease, with a two-to four-fold increased risk of peripheral vascular disease (PVD) and coronary artery disease (CAD) associated with this condition (11)(12)(13)(14).…”
Section: Introductionmentioning
confidence: 99%